// App-Quantinova.ai

FRI0618 (2017) : ADALIMUMAB IN NON-INFECTIOUS UVEITIS – EFFICACY ACROSS DIFFERENT ETIOLOGIES IN THE VISUAL I AND VISUAL II TRIALS

Researchers

Presenter

  • P.T. Merrill

Principal Investigators

  • A. Vitale

  • M. Zierhut

  • E. Forton

  • H. Goto

  • M. Kron

  • S. Tari

  • S. Pathai

Medical Centers

  • Rush University Medical Center, Chicago, IL

  • University of Utah, Salt Lake City, Utah, United States

  • University of Tuebingen Institute of Pathology, Tuebingen, Germany

  • University of Montreal, Montreal, QC, Canada

  • Tokyo Medical and Dental University, Tokyo, Japan

  • AbbVie Deutschland GmbH & Co, KG, GPRD, Ludwigshafen, Germany

  • AbbVie Inc., North Chicago, Illinois, United States

  • AbbVie Ltd, Maidenhead, United Kingdom

Locations

  • United States

  • Germany

  • Canada

  • Japan

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Ophthalmology (OP)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

  • Prednisone

Outcome

  • N/A

Study Design

  • Placebo Control

  • Double Blind/Blinded

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved